Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy

Bianca Berghuis*, Carolien G F de Kovel, Loretta van Iterson, Robert J. Lamberts, Josemir W. Sander, Dick Lindhout, Bobby P. C. Koeleman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: De novo SCN8A missense mutations have been identified as a rare dominant cause of epileptic encephalopathy. We described a person with epileptic encephalopathy associated with a mosaic deletion of the SCN8A gene.

Methods: Array comparative genome hybridization was used to identify chromosomal abnormalities. Next Generation Sequencing was used to screen for variants in known and candidate epilepsy genes. A single nucleotide polymorphism array was used to test whether the SCN8A variants were in cis or in trans.

Results: We identified a de nova mosaic deletion of exons 2-14 of SCN8A, and a rare maternally inherited missense variant on the other allele in a woman presenting with absence seizures, challenging behavior, intellectual disability and QRS-fragmentation on the ECG. We also found a variant in SCN5A.

Conclusions: The combination of a rare missense variant with a de nova mosaic deletion of a large part of the SCN8A gene suggests that other possible mechanisms for SCN8A mutations may cause epilepsy; loss of function, genetic modifiers and cellular interference may play a role. This case expands the phenotype associated with SCN8A mutations, with absence epilepsy and regression in language and memory skills. (C) 2015 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)141-144
Number of pages4
JournalEpilepsy Research
Volume115
DOIs
Publication statusPublished - Sept 2015

Keywords

  • SCN8A
  • Epileptic encephalopathy
  • SCN5A
  • fQRS
  • Mosaicism
  • SODIUM-CHANNEL SCN8A
  • GENETIC-ANALYSIS
  • ENCEPHALOPATHY
  • MUTATION
  • MODIFIER
  • SUDEP

Fingerprint

Dive into the research topics of 'Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy'. Together they form a unique fingerprint.

Cite this